Cargando…

Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report

BACKGROUND: The population of uncontrolled asthma patients represents a large therapeutic burden. The PDE3-inhibitor enoximone is a strong and quick bronchodilator and is known to successfully treat life-threatening bronchial asthma (status asthmaticus). Translational mice models showed anti-inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beute, Jan, Boermans, Pieter, KleinJan, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575614/ https://www.ncbi.nlm.nih.gov/pubmed/34760031 http://dx.doi.org/10.1155/2021/7456208

Ejemplares similares

(Oral) enoximone in asthma
por: Beute, Jan
Publicado: (2020)

Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children
por: Beute, Jan, et al.
Publicado: (2022)

Enoximone in status asthmaticus
por: Schulz, Oscar, et al.
Publicado: (2020)

Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
por: Gallizzi, F, et al.
Publicado: (2001)

Influence of enoximone and dobutamine upon liver perfusion and function in fluid optimized septic patients
por: Kern, H, et al.
Publicado: (2000)

PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells
por: Beute, Jan, et al.
Publicado: (2020)

Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy
por: Ghio, Stefano, et al.
Publicado: (2003)

PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
por: van der Lee, Robin, et al.
Publicado: (2016)

In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia
por: Boulos, Joelle C., et al.
Publicado: (2023)

In vivo depletion of lung CD11c(+) dendritic cells during allergen challenge abrogates the characteristic features of asthma
por: van Rijt, Leonie S., et al.
Publicado: (2005)

Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
por: Wang, Alberta L., et al.
Publicado: (2021)

Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: den Uil, Corstiaan A., et al.
Publicado: (2014)

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
por: Metra, Marco, et al.
Publicado: (2009)

The use of real-world data in drug repurposing
por: Park, Kyungsoo
Publicado: (2021)

Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020)

From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
por: Novembre, Elio, et al.
Publicado: (2022)

Asthma and Fixed Airways Obstruction: Real Life Aspects
por: Buonamico, Enrico, et al.
Publicado: (2023)

Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis
por: Mande, Prashant P., et al.
Publicado: (2017)

Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study
por: Bonaccorso, Angela, et al.
Publicado: (2021)

Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022)

Real-life cost-effectiveness of benralizumab in patients with severe asthma
por: Padilla-Galo, A., et al.
Publicado: (2021)

Control of asthma in real life: still a valuable goal?
por: Papaioannou, Andriana I., et al.
Publicado: (2015)

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
por: Pérez de Llano, Luis A, et al.
Publicado: (2022)

Miofrenuloplasty for Full Functional Tongue Release in Ankyloglossia in Adults and Adolescents—Preliminary Report and Step-by-Step Technique Showcase
por: Bargiel, Jakub, et al.
Publicado: (2021)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD
por: Backer, Vibeke, et al.
Publicado: (2020)

Next steps in precision approaches for asthma-proteomics and asthma endotypes
por: Brasier, Allan R.
Publicado: (2022)

Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?
por: Braido, Fulvio, et al.
Publicado: (2012)

1-year prospective real life monitoring of asthma control and quality of life in Italy
por: Terzano, Claudio, et al.
Publicado: (2012)

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience
por: Licari, Amelia, et al.
Publicado: (2017)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

Saudi Arabian real-life experience with biologic therapy in severe asthma
por: Eldaboussi, Safwat, et al.
Publicado: (2021)

Economic burden of severe asthma treatment: A real-life study()
por: López-Tiro, Jesús, et al.
Publicado: (2022)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis
por: Gerits, Evelien, et al.
Publicado: (2017)

Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
por: Kim, Hyun-Jun, et al.
Publicado: (2021)

Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
por: Frøssing, Laurits, et al.
Publicado: (2023)

Speech-guided breathing retraining in asthma: a randomised controlled crossover trial in real-life outpatient settings
por: von Bonin, Dietrich, et al.
Publicado: (2018)

A Computational Toolbox to Investigate the Metabolic Potential and Resource Allocation in Fission Yeast
por: Grigaitis, Pranas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfcip4vcm1imncbisdi8d9gedu